Factors contributing to delays in initiation of front-line cervical cancer therapy: disparities in a diverse south Florida population.

Objective: Delay in initiating cervical cancer treatment may impact outcomes. In a cohort of patients initially treated by surgery, chemoradiation, chemotherapy, or in a clinical trial, we aim to define factors contributing to prolonged time to treatment initiation.

Methods: Data from patients initiating treatment for cervical cancer at a single institution was abstracted.